semaglutide patent novo nordisk New Delhi, March 19, 2026 – On Friday, the key on semaglutide—the active molecule in Nordisk's blockbuster drugs Ozempic and Wegovy—expired in India, marking a pivotal shift in the country's Off-patent semaglutide in 2026: the
Pay in 4 interest-free payments of $7.16 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)



















